These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29266169)

  • 1. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.
    Lemmers M; Verschoor MAC; Bossuyt PM; Huirne JAF; Spinder T; Nieboer TE; Bongers MY; Janssen IAH; Van Hooff MHA; Mol BWJ; Ankum WM; Bosmans JE;
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):294-300. PubMed ID: 29266169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial.
    Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW;
    Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MisoREST: Surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: A cohort study.
    Lemmers M; Verschoor MAC; Oude Rengerink K; Naaktgeboren C; Bossuyt PM; Huirne JAF; Janssen IAH; Radder C; Klinkert ER; Langenveld J; van der Voet L; Siemens FF; Bongers MY; van Hooff MH; van der Ploeg M; Sjors FPJ; Coppus SFPJ; Ankum WM; Mol BWJ;
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():83-89. PubMed ID: 28209537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.
    Verschoor MA; Lemmers M; Bossuyt PM; Graziosi GC; Hajenius PJ; Hendriks DJ; van Hooff MA; van Meurs HS; Opmeer BC; van Tulder MW; Bouwma L; Catshoek R; Geomini P; Klinkert ER; Langenveld J; Nieboer TE; van der Ploeg JM; Radder CM; Spinder T; van der Voet LF; Mol BW; Huirne JA; Ankum WM
    BMC Pregnancy Childbirth; 2013 May; 13():102. PubMed ID: 23638956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility and obstetric outcomes after curettage versus expectant management in randomised and non-randomised women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Lemmers M; Verschoor MAC; Overwater K; Bossuyt PM; Hendriks D; Hemelaar M; Schutte JM; Adriaanse AH; Ankum WM; Huirne JAF; Mol BWJ
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():78-82. PubMed ID: 28199872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial).
    van den Berg J; Hamel CC; Snijders MP; Coppus SF; Vandenbussche FP
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):443. PubMed ID: 31775677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis.
    Sotiriadis A; Makrydimas G; Papatheodorou S; Ioannidis JP
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1104-13. PubMed ID: 15863551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatments for incomplete miscarriage.
    Kim C; Barnard S; Neilson JP; Hickey M; Vazquez JC; Dou L
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD007223. PubMed ID: 28138973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatments for incomplete miscarriage.
    Neilson JP; Gyte GM; Hickey M; Vazquez JC; Dou L
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007223. PubMed ID: 23543549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misoprostol versus expectant management in women with incomplete first-trimester miscarriage after failed primary misoprostol treatment: A randomized clinical trial.
    Ali MK; Emam SM; Abdel-Aleem MA; Sobh AMA
    Int J Gynaecol Obstet; 2021 Sep; 154(3):558-564. PubMed ID: 33615468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised trial of surgical, medical and expectant management of first trimester spontaneous miscarriage.
    Shelley JM; Healy D; Grover S
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):122-7. PubMed ID: 15760312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage--a randomised controlled trial.
    Kong GW; Lok IH; Yiu AK; Hui AS; Lai BP; Chung TK
    Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):170-7. PubMed ID: 23488984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol versus manual vacuum aspiration for treatment of first-trimester incomplete miscarriage in a low-resource setting: A randomized controlled trial.
    Nwafor JI; Agwu UM; Egbuji CC; Ekwedigwe KC
    Niger J Clin Pract; 2020 May; 23(5):638-646. PubMed ID: 32367870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of expectant vs active management for treatment of persistent pregnancies of unknown location.
    Walter JR; Barnhart KT; Koelper NC; Santoro NF; Zhang H; Thomas TR; Huang H; Harvie HS;
    Am J Obstet Gynecol; 2024 Sep; 231(3):328.e1-328.e11. PubMed ID: 38552817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach to evaluate the efficacy of vaginal misoprostol administered for a rapid management of first trimester spontaneous onset incomplete abortion, in comparison to surgical curettage.
    Patua B; Dasgupta M; Bhattacharyya SK; Bhattacharya S; Hasan SH; Saha S
    Arch Gynecol Obstet; 2013 Dec; 288(6):1243-8. PubMed ID: 23708389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expectant management of incomplete abortion in the first trimester.
    Pauleta JR; Clode N; Graça LM
    Int J Gynaecol Obstet; 2009 Jul; 106(1):35-8. PubMed ID: 19329115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized outpatient clinical trial of medical evacuation and surgical curettage in incomplete miscarriage.
    Sahin HG; Sahin HA; Kocer M
    Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):141-4. PubMed ID: 11763977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.